422.09
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $422.09, with a volume of 828.53K.
It is up +2.28% in the last 24 hours and up +0.80% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$412.70
Open:
$415
24h Volume:
828.53K
Relative Volume:
0.76
Market Cap:
$91.54B
Revenue:
$201.11B
Net Income/Loss:
$4.95B
P/E Ratio:
18.76
EPS:
22.4991
Net Cash Flow:
$6.29B
1W Performance:
+6.99%
1M Performance:
+0.80%
6M Performance:
+35.49%
1Y Performance:
+19.49%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
422.09 | 91.54B | 201.11B | 4.95B | 6.29B | 22.50 |
|
UNH
Unitedhealth Group Inc
|
378.52 | 339.76B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
87.74 | 112.22B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
CI
Cigna Group
|
283.34 | 74.87B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
433.50 | 52.05B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-29-26 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-08-26 | Initiated | Evercore ISI | In-line |
| Feb-03-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
CVS Health Trades at a Discount to Industry: How to Play the Stock? - Zacks Investment Research
2 Stocks to Buy Hand Over Fist in October - The Motley Fool
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research
Elevance Health stock sets October 21 earnings date - AD HOC NEWS
Third-quarter results are set for 6 a.m. Oct. 21, before Elevance Health's 8:30 a.m. call. - Stock Titan
Elevance Health, Inc. Actuals & Estimates (NYSE:ELV) - TradingView
ANTM5405194 Bond Profile: Coupon and Redemption - TradingView
Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Zacks Investment Research
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock Forecasts - Yahoo Finance
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins - Yahoo Finance
Elevance Health Unveils 2027 Medicare Advantage Plans, Ticker EL - GuruFocus
Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support - Business Wire
Elevance Health (ELV) Is Back In The Spotlight, What Is Drawing Attention? - Simply Wall Street
Elevance Health, Inc. (ELV) Stock forecasts - Yahoo Finance Singapore
ANTM5815521 Bond Profile: Coupon and Redemption - TradingView
ANTM3707029 Bond Profile: Coupon and Redemption - TradingView
ANTM3684374 Bond Profile: Coupon and Redemption - TradingView
Elevance Health's Quarterly Earnings Preview: What You Need to Know - inkl
Elevance Health's Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
AE1J Bond Profile: Coupon and Redemption - TradingView
Free cash flow per share of Elevance Health, Inc. – HAN:A58 - TradingView
Elevance Health on Pace for Longest Losing Streak Since September 2022 -- Data Talk - Moomoo
ANTM3670950 Bond Profile: Coupon and Redemption - TradingView
ANTM4880736 Bond Profile: Coupon and Redemption - TradingView
Elevance Health stock last trades at USD 393.56 on September 28, 2026 - AD HOC NEWS
ANTM5923066 Bond Profile: Coupon and Redemption - TradingView
Could Elevance Health (NYSE:ELV) Reset Its Market Story? - Kalkine Media
Elevance Health stock weighs a raised EPS outlook - AD HOC NEWS
ANTM3667634 Bond Profile: Coupon and Redemption - TradingView
The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipient - GlobeNewswire Inc.
ANTM5405192 Bond Profile: Coupon and Redemption - TradingView
Elevance Health stock heads into the open after a 0.8 percent gain - AD HOC NEWS
Elevance Health stock carries a USD 27 adjusted EPS outlook - AD HOC NEWS
ANTM4983276 Bond Profile: Coupon and Redemption - TradingView
AM Best withdraws ratings of Elevance Health's Hawaii captive - Captive Insurance Times
AM Best withdraws ratings of Elevance Health's Hawaii captive - Captive Insurance Times
Elevance Health stock heads into the open after a 0.45 percent drop - AD HOC NEWS
How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet - Zacks Investment Research
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed - Yahoo Finance
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
NY Surgeons Say Elevance Penalty Policy Is Anticompetitive - law360.com
Can Carelon Drive Elevance Health's Future Earnings Growth? - Eastern Progress
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock forecasts - Yahoo Finance Australia
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elevance Health Inc Stock (ELV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BOUDREAUX GAIL | President and CEO |
Jul 17 '26 |
Buy |
367.79 |
2,725 |
1,002,230 |
171,976 |
| CLARK R KERRY | Director |
Jul 07 '26 |
Proposed Sale |
419.91 |
1,500 |
629,865 |
0 |
| Penczek Ronald W | CAO & Controller |
Jun 12 '26 |
Sale |
403.16 |
369 |
148,766 |
3,740 |
| RONALD WILLIAM PENCZEK | Officer |
Jun 12 '26 |
Proposed Sale |
403.16 |
369 |
148,767 |
0 |
| Dixon Robert L JR | Director |
Jun 11 '26 |
Proposed Sale |
401.76 |
151 |
60,666 |
0 |
| Dixon Robert L JR | Director |
Jun 11 '26 |
Sale |
401.77 |
151 |
60,667 |
10,734 |
| Penczek Ronald W | CAO & Controller |
May 19 '26 |
Option Exercise |
294.30 |
1,531 |
450,579 |
5,640 |
| Penczek Ronald W | CAO & Controller |
May 19 '26 |
Sale |
403.13 |
1,531 |
617,192 |
4,109 |
| RONALD WILLIAM PENCZEK | Officer |
May 19 '26 |
Proposed Sale |
403.13 |
1,531 |
617,192 |
0 |
| SCHULMAN AMY W | Director |
Mar 12 '26 |
Sale |
287.50 |
26 |
7,475 |
218 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):